wanhua(SH:600309) Mei Ri Jing Ji Xin Wen·2025-10-24 11:20Group 1 - Wanhua Chemical (SH 600309) announced on October 24 that its fourth board meeting of the ninth session for 2025 was held via communication voting, discussing the proposal to increase the daily related transaction limit for 2025 [1] - For the first half of 2025, Wanhua Chemical's revenue composition was as follows: chemical raw materials and chemical products manufacturing accounted for 98.88%, other industries accounted for 0.72%, and other businesses accounted for 0.4% [1] - As of the report date, Wanhua Chemical's market capitalization was 192.4 billion yuan [1] Group 2 - In 2023, China's innovative pharmaceuticals have generated $80 billion in overseas licensing deals, indicating a robust performance in the biopharmaceutical secondary market [1] - Despite the strong performance in the secondary market, fundraising in the primary market has encountered challenges, as noted by Lu Gang, a partner at Chuangdong Investment [1]